Loading
Laboratiorio Reig Jofre Stock: price and insider trades · Spain
No insider purchase over the last 90 days. The latest, by KILUVA S.A., was filed 24 Apr 2026.
Laboratiorio Reig Jofre: what insiders have been doing
This page follows insider dealings at Laboratiorio Reig Jofre as filed with CNMV, a company from the Health Care sector based in Sant Joan Despí, Spain. The group dates from 1929. Its latest reported headcount is 1,429 employees (2024). In the past year (20 October 2025 to 20 October 2026), 1 filing came from 1 insider.
The flow runs one way only: 1 insider bought (1 purchase totalling €4,632) and nobody sold on the market. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Those buying include 1 chief executive. At €4,632, the purchase published on 24 April 2026 by Kiluva S.A. is the largest of the period (0.0022% of market cap).
The most recent open-market purchase was published on 24 April 2026, 183 days ago.
With 1 filing in twelve months, the company is quieter than the median of 7 filings across the 101 companies we follow on the same exchange. Since 2022, the database holds 5 purchases and no sales by insiders of the company.
Elsewhere in the same sector, our signals recently picked up insider purchases at Vivos Inc and Anixa Biosciences Inc. Every figure here comes from the filings published by CNMV and describes the past, not future prices; it is not investment advice.
Insider Decl.
5
Thresholds
n/a
Buy Volume
€65,372
5 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleKiluva S.A.1 buy
Since the insiders bought
- -1.9%Entry €2.70 · Close at T+90 €2.65
- -9.2%Entry €2.62 · Close at T+365 €2.38
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 16,112 of 26,286 companies
44.4
score / 100
Value42
Quality47
FCF yld-7.8%
Earn yld2.3%
EV/EBITDA9.4x
ROE3.1%
Gross mgn59%
Net mgn1.5%
Debt/EBITDA2.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
€2.61
Analyst consensus
Income statement
Revenue€331.1M
Gross profit€195.8M59% margin
EBITDA€32.5M10% margin
Net income€5.0M2.1% margin
Valuation
PER (trailing)32.6x
PER (forward)21.8x
P/Book1.0x
Beta0.94
Balance sheet & cash
Market cap€214.2M
Total debt€91.5M
Free Cash Flow-€16.8M
Debt / Equity54%
Profitability & ownership
ROE3.1%
ROA1.4%
% insiders78.5%
% institutions5.9%
Last declaration on 24 April 2026
Declarations5 total
1,748 shares@ €2.650.0022% mcap100.0% of flowShareXMADISIN ES0165359029CNMV:2026056459
Canonical exit: 14 Jul 2026 (T+90)
12,030 shares@ €2.700.015% mcap53.5% of flowShareXMADISIN ES0165359029CNMV:2022149608
Canonical exit: 22 Feb 2023 (T+90)
675 shares@ €2.412.7% of flowShareXMADISIN ES0165359029CNMV:2022143639
Canonical exit: 9 Feb 2023 (T+90)
5,000 shares@ €2.3519.3% of flowShareXMADISIN ES0165359029CNMV:2022141168
Canonical exit: 2 Feb 2023 (T+90)
6,734 shares@ €2.2124.5% of flowShareXMADISIN ES0165359029CNMV:2022138892
Canonical exit: 26 Jan 2023 (T+90)
5 of 5 declarations
About Laboratiorio Reig Jofre
Laboratiorio Reig Jofre is a company specialized in the health and pharmaceutical sector, providing a range of pharmaceutical and health products. It is listed on the XMAD market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
